A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
NCT00888264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152
Last updated 2010-12-22
Summary
The purpose of this NIS is to obtain data on how AAPs are used in DSM-IV-TR Bipolar I and II Disorder, in the course of a major depressive episode. Both the parameters of use of AAPs and clinical evaluation will be recorded and potential differences that may exist due to epidemiological factors or comorbidities will be analyzed.
Conditions
- Bipolar Disorders
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- Belgium
Study Locations
More Related Trials
-
Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up
NCT01255982 ·Status: COMPLETED
-
Depressive Symptoms in Acute Manic Episode
NCT00690248 ·Status: COMPLETED
-
Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression
NCT01028196 ·Status: COMPLETED
-
Effect of Quetiapine on Brain Activity Patterns in Patients With Heightened Risk of Bipolar Disorder
NCT02451306 ·Status: UNKNOWN ·Phase: NA
-
The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours
NCT01377896 ·Status: COMPLETED
-
Improving Early Recognition and Intervention in At-risk Stages of Bipolar Disorders
NCT02456545 ·Status: COMPLETED
-
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
NCT03259555 ·Status: COMPLETED ·Phase: PHASE3
-
Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression
NCT04923204 ·Status: COMPLETED
-
European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes
NCT01239589 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
NCT01725308 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
NCT00312494 ·Status: COMPLETED ·Phase: PHASE3
-
Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)
NCT00764478 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment and Outcome of Early Onset Bipolar Disorder
NCT00048802 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
NCT02050854 ·Status: COMPLETED
-
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
NCT03257865 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
NCT00080314 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01822678 ·Status: COMPLETED ·Phase: PHASE2
-
Aripiprazole in Patients With Acute Mania
NCT00095511 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Aripiprazole in Patients With a History of Bipolar Disorder
NCT00036348 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Relapse & Recurrence of Bipolar Depression
NCT00961961 ·Status: COMPLETED ·Phase: PHASE4
-
A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)
NCT01344733 ·Status: COMPLETED
-
Predictors of Recurrence in Bipolar Disorder in Spain
NCT00690859 ·Status: COMPLETED
-
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
NCT00071253 ·Status: TERMINATED ·Phase: PHASE4
-
A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
NCT00335205 ·Status: UNKNOWN ·Phase: PHASE4
-
A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
NCT00282464 ·Status: COMPLETED ·Phase: PHASE3